Allogenic NK Cells
/ Kian Immune Cell Company
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 19, 2025
Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas
(clinicaltrials.gov)
- P2 | N=40 | Recruiting | Sponsor: Marzieh Ebrahimi | Trial completion date: Feb 2025 ➔ Nov 2027 | Trial primary completion date: Feb 2025 ➔ Nov 2025
Trial completion date • Trial primary completion date • Brain Cancer • CNS Tumor • Glioblastoma • Glioma • Malignant Glioma • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1